ADC Therapeutics' low P/S ratio may be due to poor growth an...

ADC Therapeutics' low P/S ratio may be due to poor growth and declining revenue. The company's underwhelming revenue outlook and shareholders' pessimism on revenue prospects contribute to the low P/S. The share price is unlikely to rise strongly soon.